Скачать с ютуб NUTRIVENTION: a high-fiber dietary intervention improves biomarkers in precursor disorders в хорошем качестве
NUTRIVENTION: a high-fiber dietary intervention improves biomarkers in precursor disorders
2 месяца назад
Speaker: Urvi Shah
Institution: Memorial Sloan Kettering Cancer Center
Event: ASH 2024
Format: Interview
Subject: Multiple Myeloma
Subject: Smoldering myeloma
Field: Treatment
Field: Trial Updates
Trial: NUTRIVENTION
precursor plasma cell disorders
MGUS
SMM
high-fiber dietary intervention
NCT04920084
BMI
insulin resistance
microbiome diversity
and immune function
inflammation
anti-tumor immunity
nutrition
diet
Скачать бесплатно и смотреть ютуб-видео без блокировок NUTRIVENTION: a high-fiber dietary intervention improves biomarkers in precursor disorders в качестве 4к (2к / 1080p)
У нас вы можете посмотреть бесплатно NUTRIVENTION: a high-fiber dietary intervention improves biomarkers in precursor disorders или скачать в максимальном доступном качестве, которое было загружено на ютуб. Для скачивания выберите вариант из формы ниже:
Загрузить музыку / рингтон NUTRIVENTION: a high-fiber dietary intervention improves biomarkers in precursor disorders в формате MP3:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
NUTRIVENTION: a high-fiber dietary intervention improves biomarkers in precursor disorders
Urvi Shah, MD, Memorial Sloan Kettering Cancer Center, New York City, NY, presents the encouraging findings of the NUTRIVENTION trial (NCT04920084), a study investigating the effects of a high-fiber plant-based diet in patients with monoclonal gammopathy of undetermined significance (MGUS) or smoldering multiple myeloma (SMM). In this trial, the intervention has improved body mass index (BMI), insulin resistance, microbiome diversity, and immune function. Dr Shah highlights that the diet also modulated inflammation, suggesting enhanced anti-tumor immunity and the possibility of reduced risk of progression to multiple myeloma (MM). This interview took place at the 66th ASH Annual Meeting and Exposition, held in San Diego, CA. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Comments
